{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:37:20Z","timestamp":1794465440723,"version":"4.9.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52812-6","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T05:02:02Z","timestamp":1727758922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Cheesue","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9184-5882","authenticated-orcid":false,"given":"Hyeok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7425-8192","authenticated-orcid":false,"given":"Woo-Sup","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9366-9026","authenticated-orcid":false,"given":"Mungyo","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangjun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikyung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungpil","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiwon","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-9546","authenticated-orcid":false,"given":"Hun-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5210-7430","authenticated-orcid":false,"given":"Byung\u2010Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"52812_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","volume":"389","author":"GW Reed","year":"2017","unstructured":"Reed, G. W., Rossi, J. E. & Cannon, C. P. Acute myocardial infarction. Lancet 389, 197\u2013210 (2017).","journal-title":"Lancet"},{"key":"52812_CR2","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMra1606915","volume":"376","author":"JL Anderson","year":"2017","unstructured":"Anderson, J. L. & Morrow, D. A. Acute myocardial infarction. N. Engl. J. Med. 376, 2053\u20132064 (2017).","journal-title":"N. Engl. J. Med."},{"key":"52812_CR3","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1161\/CIRCRESAHA.120.317200","volume":"127","author":"E Vafadarnejad","year":"2020","unstructured":"Vafadarnejad, E. et al. Dynamics of cardiac neutrophil diversity in murine myocardial infarction. Circ. Res. 127, e232\u2013e249 (2020).","journal-title":"Circ. Res."},{"key":"52812_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fcvm.2019.00025","volume":"6","author":"S-L Puhl","year":"2019","unstructured":"Puhl, S.-L. & Steffens, S. Neutrophils in post-myocardial infarction inflammation: damage vs. resolution? Front. Cardiovasc. Med. 6, 25 (2019).","journal-title":"Front. Cardiovasc. Med."},{"key":"52812_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nri.2017.10","volume":"17","author":"O Soehnlein","year":"2017","unstructured":"Soehnlein, O., Steffens, S., Hidalgo, A. & Weber, C. Neutrophils as protagonists and targets in chronic inflammation. Nat. Rev. Immunol. 17, 248\u2013261 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"52812_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-1536-6-11","volume":"6","author":"Y Ma","year":"2013","unstructured":"Ma, Y., Yabluchanskiy, A. & Lindsey, M. L. Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenes. Tissue Repair 6, 1\u201310 (2013).","journal-title":"Fibrogenes. Tissue Repair"},{"key":"52812_CR7","doi-asserted-by":"publisher","first-page":"H500","DOI":"10.1152\/ajpheart.00381.2014","volume":"308","author":"L Ge","year":"2015","unstructured":"Ge, L. et al. Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy. Am. J. Physiol. Heart Circ. Physiol. 308, H500\u2013H509 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"52812_CR8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.bcp.2011.11.003","volume":"83","author":"SR Alam","year":"2012","unstructured":"Alam, S. R., Newby, D. E. & Henriksen, P. A. Role of the endogenous elastase inhibitor, elafin, in cardiovascular injury: from epithelium to endothelium. Biochem. Pharmacol. 83, 695\u2013704 (2012).","journal-title":"Biochem. Pharmacol."},{"key":"52812_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cardiores.2003.10.011","volume":"61","author":"J Vinten-Johansen","year":"2004","unstructured":"Vinten-Johansen, J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc. Res. 61, 481\u2013497 (2004).","journal-title":"Cardiovasc. Res."},{"key":"52812_CR10","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1161\/ATVBAHA.120.314807","volume":"40","author":"PR Nagareddy","year":"2020","unstructured":"Nagareddy, P. R. et al. NETosis is required for S100A8\/A9-induced granulopoiesis after myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 40, 2805\u20132807 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"52812_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/ATVBAHA.117.310333","volume":"38","author":"R Batra","year":"2018","unstructured":"Batra, R. et al. IL-1\u03b2 (interleukin-1\u03b2) and TNF-\u03b1 (tumor necrosis factor-\u03b1) impact abdominal aortic aneurysm formation by differential effects on macrophage polarization. Arterioscler. Thromb. Vasc. Biol. 38, 457\u2013463 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"52812_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj2101","volume":"7","author":"AJ Monteith","year":"2021","unstructured":"Monteith, A. J., Miller, J. M., Maxwell, C. N., Chazin, W. J. & Skaar, E. P. Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens. Sci. Adv. 7, eabj2101 (2021).","journal-title":"Sci. Adv."},{"key":"52812_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","volume":"110","author":"NG Frangogiannis","year":"2012","unstructured":"Frangogiannis, N. G. Regulation of the inflammatory response in cardiac repair. Circ. Res. 110, 159\u2013173 (2012).","journal-title":"Circ. Res."},{"key":"52812_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/imr.12453","volume":"273","author":"MC Greenlee\u2010Wacker","year":"2016","unstructured":"Greenlee\u2010Wacker, M. C. Clearance of apoptotic neutrophils and resolution of inflammation. Immunol. Rev. 273, 357\u2013370 (2016).","journal-title":"Immunol. Rev."},{"key":"52812_CR15","doi-asserted-by":"crossref","unstructured":"Moon S., Hong J., Go S., Kim B.-S. Immunomodulation for tissue repair and regeneration. Tissue Eng. Regen. Med. 20, 389\u2013409 (2023).","DOI":"10.1007\/s13770-023-00525-0"},{"key":"52812_CR16","first-page":"187","volume":"38","author":"M Horckmans","year":"2017","unstructured":"Horckmans, M. et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur. Heart J. 38, 187\u2013197 (2017).","journal-title":"Eur. Heart J."},{"key":"52812_CR17","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1172\/JCI1112","volume":"101","author":"VA Fadok","year":"1998","unstructured":"Fadok, V. A. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Investig. 101, 890\u2013898 (1998).","journal-title":"J. Clin. Investig."},{"key":"52812_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1182\/blood-2013-07-514992","volume":"123","author":"AS Savchenko","year":"2014","unstructured":"Savchenko, A. S. et al. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia\/reperfusion injury in mice. Blood 123, 141\u2013148 (2014).","journal-title":"Blood"},{"key":"52812_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14780","volume":"8","author":"J Garc\u00eda-Prieto","year":"2017","unstructured":"Garc\u00eda-Prieto, J. et al. Neutrophil stunning by metoprolol reduces infarct size. Nat. Commun. 8, 14780 (2017).","journal-title":"Nat. Commun."},{"key":"52812_CR20","unstructured":"Pharmaceuticals N., Novartis. A. Safety, tolerability and efficacy study in chronic obstructive pulmonary disease (COPD) Patients With QBM076). https:\/\/ClinicalTrials.gov\/show\/NCT01972776 (2013)."},{"key":"52812_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S2213-2600(16)30227-2","volume":"4","author":"PM O\u2019Byrne","year":"2016","unstructured":"O\u2019Byrne, P. M. et al. Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial. Lancet Respir. Med. 4, 797\u2013806 (2016).","journal-title":"Lancet Respir. Med."},{"key":"52812_CR22","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nm1248","volume":"11","author":"H Jonsson","year":"2005","unstructured":"Jonsson, H., Allen, P. & Peng, S. L. Inflammatory arthritis requires Foxo3a to prevent Fas ligand\u2013induced neutrophil apoptosis. Nat. Med. 11, 666\u2013671 (2005).","journal-title":"Nat. Med."},{"key":"52812_CR23","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/ni1407","volume":"7","author":"A M\u00f3csai","year":"2006","unstructured":"M\u00f3csai, A. et al. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat. Immunol. 7, 1326\u20131333 (2006).","journal-title":"Nat. Immunol."},{"key":"52812_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pharmthera.2014.11.008","volume":"147","author":"I Mitroulis","year":"2015","unstructured":"Mitroulis, I. et al. Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacol. Ther. 147, 123\u2013135 (2015).","journal-title":"Pharmacol. Ther."},{"key":"52812_CR25","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1021\/acsbiomaterials.8b01062","volume":"4","author":"PW Bisso","year":"2018","unstructured":"Bisso, P. W., Gaglione, S., Guimar\u00e3es, P. P., Mitchell, M. J. & Langer, R. Nanomaterial interactions with human neutrophils. ACS Biomater. Sci. Eng. 4, 4255\u20134265 (2018).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"52812_CR26","doi-asserted-by":"publisher","first-page":"14947","DOI":"10.1073\/pnas.1820276116","volume":"116","author":"J Park","year":"2019","unstructured":"Park, J. et al. Intravascular innate immune cells reprogrammed via intravenous nanoparticles to promote functional recovery after spinal cord injury. Proc. Natl. Acad. Sci. 116, 14947\u201314954 (2019).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"52812_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jconrel.2019.02.025","volume":"300","author":"E Saito","year":"2019","unstructured":"Saito, E. et al. Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation. J. Control. Release 300, 185\u2013196 (2019).","journal-title":"J. Control. Release"},{"key":"52812_CR28","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nm1468","volume":"12","author":"AG Rossi","year":"2006","unstructured":"Rossi, A. G. et al. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat. Med. 12, 1056\u20131064 (2006).","journal-title":"Nat. Med."},{"key":"52812_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.bjc.6603509","volume":"96","author":"C Benson","year":"2007","unstructured":"Benson, C. et al. A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days. Br. J. Cancer 96, 29\u201337 (2007).","journal-title":"Br. J. Cancer"},{"key":"52812_CR30","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1016\/j.ejca.2010.08.001","volume":"46","author":"C Le Tourneau","year":"2010","unstructured":"Le Tourneau, C. et al. Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies. Eur. J. Cancer 46, 3243\u20133250 (2010).","journal-title":"Eur. J. Cancer"},{"key":"52812_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0006-3495(88)83078-9","volume":"53","author":"SI Simon","year":"1988","unstructured":"Simon, S. I. & Schmid-Sch\u00f6nbein, G. Biophysical aspects of microsphere engulfment by human neutrophils. Biophys. J. 53, 163\u2013173 (1988).","journal-title":"Biophys. J."},{"key":"52812_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/adma.201203218","volume":"25","author":"X Sun","year":"2013","unstructured":"Sun, X., Guo, S., Chung, C. S., Zhu, W. & Sun, S. A sensitive H2O2 assay based on dumbbell\u2010like PtPd\u2010Fe3O4 nanoparticles. Adv. Mater. 25, 132\u2013136 (2013).","journal-title":"Adv. Mater."},{"key":"52812_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0006-8993(94)01291-O","volume":"671","author":"PA Hyslop","year":"1995","unstructured":"Hyslop, P. A., Zhang, Z., Pearson, D. V. & Phebus, L. A. Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat: correlation with the cytotoxic potential of H2O2 in vitro. Brain Res. 671, 181\u2013186 (1995).","journal-title":"Brain Res."},{"key":"52812_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"52812_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0168-3659(01)00530-2","volume":"79","author":"K Avgoustakis","year":"2002","unstructured":"Avgoustakis, K. et al. PLGA\u2013mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Release 79, 123\u2013135 (2002).","journal-title":"J. Control. Release"},{"key":"52812_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jddst.2018.03.024","volume":"45","author":"X Lin","year":"2018","unstructured":"Lin, X., Yang, H., Su, L., Yang, Z. & Tang, X. Effect of size on the in vitro\/in vivo drug release and degradation of exenatide-loaded PLGA microspheres. J. Drug Deliv. Sci. Technol. 45, 346\u2013356 (2018).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"52812_CR37","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1021\/mp300559v","volume":"10","author":"AK Mohammad","year":"2013","unstructured":"Mohammad, A. K. & Reineke, J. J. Quantitative detection of PLGA nanoparticle degradation in tissues following intravenous administration. Mol. Pharm. 10, 2183\u20132189 (2013).","journal-title":"Mol. Pharm."},{"key":"52812_CR38","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1021\/acsbiomaterials.0c01228","volume":"6","author":"J Yoo","year":"2020","unstructured":"Yoo, J. & Won, Y.-Y. Phenomenology of the initial burst release of drugs from PLGA microparticles. ACS Biomater. Sci. Eng. 6, 6053\u20136062 (2020).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"52812_CR39","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.polymdegradstab.2010.08.015","volume":"95","author":"GK Jain","year":"2010","unstructured":"Jain, G. K. et al. Mechanistic study of hydrolytic erosion and drug release behaviour of PLGA nanoparticles: influence of chitosan. Polym. Degrad. Stab. 95, 2360\u20132366 (2010).","journal-title":"Polym. Degrad. Stab."},{"key":"52812_CR40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.polymdegradstab.2016.10.017","volume":"134","author":"N Rescignano","year":"2016","unstructured":"Rescignano, N. et al. In-vitro degradation of PLGA nanoparticles in aqueous medium and in stem cell cultures by monitoring the cargo fluorescence spectrum. Polym. Degrad. Stab. 134, 296\u2013304 (2016).","journal-title":"Polym. Degrad. Stab."},{"key":"52812_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118819","volume":"572","author":"F Tamani","year":"2019","unstructured":"Tamani, F. et al. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: diprophylline dispersions. Int. J. Pharm. 572, 118819 (2019).","journal-title":"Int. J. Pharm."},{"key":"52812_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1049\/iet-nbt.2012.0012","volume":"7","author":"AS Hussein","year":"2013","unstructured":"Hussein, A. S., Abdullah, N. & Ahmadun FlR. In vitro degradation of poly (D, L\u2010lactide\u2010co\u2010glycolide) nanoparticles loaded with linamarin. IET Nanobiotechnol. 7, 33\u201341 (2013).","journal-title":"IET Nanobiotechnol."},{"key":"52812_CR43","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nnano.2017.54","volume":"12","author":"J Xue","year":"2017","unstructured":"Xue, J. et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat. Nanotechnol. 12, 692\u2013700 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"52812_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.celrep.2014.06.044","volume":"8","author":"KD Metzler","year":"2014","unstructured":"Metzler, K. D., Goosmann, C., Lubojemska, A., Zychlinsky, A. & Papayannopoulos, V. A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell Rep. 8, 883\u2013896 (2014).","journal-title":"Cell Rep."},{"key":"52812_CR45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCHEARTFAILURE.110.957712","volume":"4","author":"KD Pendergrass","year":"2011","unstructured":"Pendergrass, K. D. et al. Temporal effects of catalase overexpression on healing after myocardial infarction. Circ Heart Fail. 4, 98\u2013106 (2011).","journal-title":"Circ Heart Fail."},{"key":"52812_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1083\/jcb.200606027","volume":"176","author":"TA Fuchs","year":"2007","unstructured":"Fuchs, T. A. et al. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176, 231\u2013241 (2007).","journal-title":"J. Cell Biol."},{"key":"52812_CR47","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.4049\/jimmunol.162.3.1692","volume":"162","author":"K Aoshiba","year":"1999","unstructured":"Aoshiba, K., Yasui, S., Hayashi, M., Tamaoki, J. & Nagai, A. Role of p38-mitogen-activated protein kinase in spontaneous apoptosis of human neutrophils. J. Immunol. 162, 1692\u20131700 (1999).","journal-title":"J. Immunol."},{"key":"52812_CR48","doi-asserted-by":"publisher","first-page":"10797","DOI":"10.1021\/acsnano.7b03190","volume":"11","author":"CA Fromen","year":"2017","unstructured":"Fromen, C. A. et al. Neutrophil\u2013particle interactions in blood circulation drive particle clearance and alter neutrophil responses in acute inflammation. ACS Nano 11, 10797\u201310807 (2017).","journal-title":"ACS Nano"},{"key":"52812_CR49","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.it.2010.05.006","volume":"31","author":"C Summers","year":"2010","unstructured":"Summers, C. et al. Neutrophil kinetics in health and disease. Trends Immunol. 31, 318\u2013324 (2010).","journal-title":"Trends Immunol."},{"key":"52812_CR50","doi-asserted-by":"publisher","first-page":"C253","DOI":"10.1152\/ajpcell.00035.2003","volume":"285","author":"Y Goto","year":"2003","unstructured":"Goto, Y., Hogg, J. C., Suwa, T., Quinlan, K. B. & van Eeden, S. F. A novel method to quantify the turnover and release of monocytes from the bone marrow using the thymidine analog 5\u2032-bromo-2\u2032-deoxyuridine. Am. J. Physiol. Cell Physiol. 285, C253\u2013C259 (2003).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"52812_CR51","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/bph.15595","volume":"179","author":"TP Martin","year":"2022","unstructured":"Martin, T. P. et al. Preclinical models of myocardial infarction: from mechanism to translation. Br. J. Pharmacol. 179, 770\u2013791 (2022).","journal-title":"Br. J. Pharmacol."},{"key":"52812_CR52","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1189\/jlb.1211601","volume":"92","author":"H Parker","year":"2012","unstructured":"Parker, H., Dragunow, M., Hampton, M. B., Kettle, A. J. & Winterbourn, C. C. Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus. J. Leukoc. Biol. 92, 841\u2013849 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"52812_CR53","doi-asserted-by":"publisher","first-page":"e903","DOI":"10.1038\/cddis.2013.362","volume":"4","author":"A Singhal","year":"2013","unstructured":"Singhal, A., Morris, V., Labhasetwar, V. & Ghorpade, A. Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress. Cell Death Dis. 4, e903\u2013e903 (2013).","journal-title":"Cell Death Dis."},{"key":"52812_CR54","first-page":"3314","volume":"7","author":"G Xu","year":"2001","unstructured":"Xu, G. & McLeod, H. L. Strategies for enzyme\/prodrug cancer therapy. Clin. Cancer Res. 7, 3314\u20133324 (2001).","journal-title":"Clin. Cancer Res."},{"key":"52812_CR55","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1021\/acsami.0c19633","volume":"13","author":"AY Heble","year":"2021","unstructured":"Heble, A. Y., Santelli, J., Armstrong, A. M., Mattrey, R. F. & Lux, J. Catalase-loaded silica nanoparticles formulated via direct surface modification as potential oxygen generators for hypoxia relief. ACS Appl. Mater. Interfaces 13, 5945\u20135954 (2021).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"52812_CR56","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1007\/s00018-019-03135-z","volume":"76","author":"A Safary","year":"2019","unstructured":"Safary, A., Akbarzadeh Khiavi, M., Omidi, Y. & Rafi, M. A. Targeted enzyme delivery systems in lysosomal disorders: an innovative form of therapy for mucopolysaccharidosis. Cell. Mol. Life Sci. 76, 3363\u20133381 (2019).","journal-title":"Cell. Mol. Life Sci."},{"key":"52812_CR57","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1053\/j.gastro.2007.08.073","volume":"133","author":"AA K\u00fchl","year":"2007","unstructured":"K\u00fchl, A. A. et al. Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 133, 1882\u20131892 (2007).","journal-title":"Gastroenterology"},{"key":"52812_CR58","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/NEN.0b013e31820d94a5","volume":"70","author":"I Moxon-Emre","year":"2011","unstructured":"Moxon-Emre, I. & Schlichter, L. C. Neutrophil depletion reduces blood-brain barrier breakdown, axon injury, and inflammation after intracerebral hemorrhage. J. Neuropathol. Exp. Neurol. 70, 218\u2013235 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"52812_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-8-103","volume":"8","author":"V Friedrich","year":"2011","unstructured":"Friedrich, V. et al. Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage. J. Neuroinflamm. 8, 1\u201312 (2011).","journal-title":"J. Neuroinflamm."},{"key":"52812_CR60","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/jcbfm.2008.75","volume":"28","author":"GD Hilton","year":"2008","unstructured":"Hilton, G. D., Stoica, B. A., Byrnes, K. R. & Faden, A. I. Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. J. Cereb. Blood Flow. Metab. 28, 1845\u20131859 (2008).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"52812_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2184.2009.00584.x","volume":"42","author":"RS Jhou","year":"2009","unstructured":"Jhou, R. S. et al. Inhibition of cyclin\u2010dependent kinases by olomoucine and roscovitine reduces lipopolysaccharide\u2010induced inflammatory responses via down\u2010regulation of nuclear factor \u03baB. Cell Prolif. 42, 141\u2013149 (2009).","journal-title":"Cell Prolif."},{"key":"52812_CR62","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1056\/NEJMx060044","volume":"355","author":"J Kinsella","year":"2006","unstructured":"Kinsella, J. Taking heart-Cardiac transplantation past, present, and future (vol 355, pg 231, 2006). N. Engl. J. Med. 355, 967\u2013967 (2006).","journal-title":"N. Engl. J. Med."},{"key":"52812_CR63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41569-018-0073-1","volume":"16","author":"R Duivenvoorden","year":"2019","unstructured":"Duivenvoorden, R. et al. Nanoimmunotherapy to treat ischaemic heart disease. Nat. Rev. Cardiol. 16, 21\u201332 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"52812_CR64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s13770-021-00419-z","volume":"19","author":"GR Ko","year":"2022","unstructured":"Ko, G. R. & Lee, J. S. Engineering of immune microenvironment for enhanced tissue remodeling. Tissue Eng. Regen. Med. 19, 221\u2013236 (2022).","journal-title":"Tissue Eng. Regen. Med."},{"key":"52812_CR65","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"52812_CR66","doi-asserted-by":"publisher","first-page":"eabd0914","DOI":"10.1126\/scitranslmed.abd0914","volume":"13","author":"B Liu","year":"2021","unstructured":"Liu, B. et al. Cell type\u2013specific microRNA therapies for myocardial infarction. Sci. Transl. Med. 13, eabd0914 (2021).","journal-title":"Sci. Transl. Med."},{"key":"52812_CR67","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson, A. & McDonald, C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell 17, 11\u201322 (2015).","journal-title":"Cell Stem Cell"},{"key":"52812_CR68","doi-asserted-by":"crossref","unstructured":"Jung M. et al. Iron oxide nanoparticle-incorporated mesenchymal stem cells for Alzheimer\u2019s disease treatment. Nano Lett., (2023).","DOI":"10.1021\/acs.nanolett.2c03682"},{"key":"52812_CR69","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s13770-021-00334-3","volume":"18","author":"T-T Van Nguyen","year":"2021","unstructured":"Van Nguyen, T.-T., Vu, N. B. & Van Pham, P. Mesenchymal stem cell transplantation for ischemic diseases: mechanisms and challenges. Tissue Eng. Regen. Med. 18, 587\u2013611 (2021).","journal-title":"Tissue Eng. Regen. Med."},{"key":"52812_CR70","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s13770-022-00467-z","volume":"19","author":"R Munderere","year":"2022","unstructured":"Munderere, R., Kim, S.-H., Kim, C. & Park, S.-H. The progress of stem cell therapy in myocardial-infarcted heart regeneration: cell sheet technology. Tissue Eng. Regen. Med. 19, 969\u2013986 (2022).","journal-title":"Tissue Eng. Regen. Med."},{"key":"52812_CR71","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrd.2017.106","volume":"16","author":"TJ Cahill","year":"2017","unstructured":"Cahill, T. J., Choudhury, R. P. & Riley, P. R. Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics. Nat. Rev. Drug Discov. 16, 699\u2013717 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"52812_CR72","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1093\/nar\/gkw236","volume":"44","author":"RL Juliano","year":"2016","unstructured":"Juliano, R. L. The delivery of therapeutic oligonucleotides. Nucleic Acids Res. 44, 6518\u20136548 (2016).","journal-title":"Nucleic Acids Res."},{"key":"52812_CR73","unstructured":"Mirna Therapeutics I. Pharmacodynamics study of MRX34, MicroRNA liposomal injection in melanoma patients with biopsy accessible lesions). https:\/\/ClinicalTrials.gov\/show\/NCT02862145 (2016)."},{"key":"52812_CR74","doi-asserted-by":"crossref","unstructured":"Zhao W., Zhao J., Rong J. Pharmacological modulation of cardiac remodeling after myocardial infarction. Oxid. Med. Cell. Longev. 2020, 8815349 (2020).","DOI":"10.1155\/2020\/8815349"},{"key":"52812_CR75","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","volume":"62","author":"X Yan","year":"2013","unstructured":"Yan, X. et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J. Mol. Cell. Cardiol. 62, 24\u201335 (2013).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"52812_CR76","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas, J. & Hughes, C. C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731\u20132738 (2004).","journal-title":"J. Immunol."},{"key":"52812_CR77","doi-asserted-by":"publisher","first-page":"16481","DOI":"10.1073\/pnas.2003603117","volume":"117","author":"S Gupta","year":"2020","unstructured":"Gupta, S. et al. Sex differences in neutrophil biology modulate response to type I interferons and immunometabolism. Proc. Natl. Acad. Sci. 117, 16481\u201316491 (2020).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"52812_CR78","doi-asserted-by":"crossref","unstructured":"Ovadia S., \u00d6zcan A., Hidalgo A. The circadian neutrophil, inside-out. J. Leukoc. Biol. 113, 555\u2013566 (2023).","DOI":"10.1093\/jleuko\/qiad038"},{"key":"52812_CR79","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/jbm.a.33220","volume":"99","author":"Y Thasneem","year":"2011","unstructured":"Thasneem, Y., Sajeesh, S. & Sharma, C. P. Effect of thiol functionalization on the hemo\u2010compatibility of PLGA nanoparticles. J. Biomed. Mater. Res. Part A 99, 607\u2013617 (2011).","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"52812_CR80","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000295791","volume":"2","author":"S Moriceau","year":"2010","unstructured":"Moriceau, S., Lenoir, G. & Witko-Sarsat, V. In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance. J. Innate Immun. 2, 260\u2013266 (2010).","journal-title":"J. Innate Immun."},{"key":"52812_CR81","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/cdd.2012.80","volume":"19","author":"A Leitch","year":"2012","unstructured":"Leitch, A. et al. Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation. Cell Death Differ. 19, 1950\u20131961 (2012).","journal-title":"Cell Death Differ."},{"key":"52812_CR82","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/eji.200939664","volume":"40","author":"AE Leitch","year":"2010","unstructured":"Leitch, A. E. et al. The cyclin\u2010dependent kinase inhibitor R\u2010roscovitine down\u2010regulates Mcl\u20101 to override pro\u2010inflammatory signalling and drive neutrophil apoptosis. Eur. J. Immunol. 40, 1127\u20131138 (2010).","journal-title":"Eur. J. Immunol."},{"key":"52812_CR83","doi-asserted-by":"publisher","first-page":"e20458","DOI":"10.1097\/MD.0000000000020458","volume":"99","author":"S Siebert","year":"2020","unstructured":"Siebert, S. et al. Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: an early phase trial. Medicine 99, e20458 (2020).","journal-title":"Medicine"},{"key":"52812_CR84","unstructured":"Center C.-S. M. Multicenter study of seliciclib (R-roscovitine) for cushing disease) https:\/\/ClinicalTrials.gov\/show\/NCT03774446 (2018)."},{"key":"52812_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18443-3","volume":"11","author":"A Volchuk","year":"2020","unstructured":"Volchuk, A., Ye, A., Chi, L., Steinberg, B. E. & Goldenberg, N. M. Indirect regulation of HMGB1 release by gasdermin D. Nat. Commun. 11, 4561 (2020).","journal-title":"Nat. Commun."},{"key":"52812_CR86","doi-asserted-by":"publisher","first-page":"e0142520","DOI":"10.1371\/journal.pone.0142520","volume":"11","author":"A Barnett-Vanes","year":"2016","unstructured":"Barnett-Vanes, A., Sharrock, A., Birrell, M. A. & Rankin, S. A single 9-colour flow cytometric method to characterise major leukocyte populations in the rat: validation in a model of LPS-induced pulmonary inflammation. PLoS One 11, e0142520 (2016).","journal-title":"PLoS One"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52812-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52812-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52812-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T05:02:15Z","timestamp":1727758935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52812-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52812"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52812-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8481"}}